Hemostemix Expands With First Cardiology Practice Acquisitions
CALGARY, Alberta — November 26, 2025. Hemostemix Inc. has taken a major step in its global clinical-commercial expansion, announcing...
Regenerative Medicine
Advertisement
Aspen Neuroscience Secures $115M to Advance Cell Therapy
SAN DIEGO, CA — November 20, 2025 — Aspen Neuroscience, a leading developer of personalized autologous cell therapies for...
ACP-01 Cell Therapy Moves Into Trial for Vascular Dementia
Calgary, Alberta — November 20, 2025 — Hemostemix Inc. announced that Dr. William R. Shankle, MS, MD, FACP, a...
Rapid Nexus Secures First FDA Clearance for Breakthrough Hemastyl® Wound-Healing Device
BREA, California — November 13, 2025: Rapid Nexus Nanotech Wound Solutions, Inc. has become the first company to receive...
Visionary Holdings Launches Stem Cell Venture for Diabetes Cure
Toronto, Canada – October 22, 2025 — Visionary Holdings Inc., a global education and technology enterprise, announced the launch...
Advertisements
Hemostemix Seeks Ethics Approval for Stem Cell Dementia Trial
CALGARY, Alberta, Oct. 9, 2025 — Hemostemix has filed for Institutional Review Board (IRB) approval of its Phase 1...
McKesson Expands Cell and Gene Therapy Access Across the U.S.
IRVING, Texas, Oct. 6, 2025 — McKesson Corporation has released new insights highlighting the rapid growth and expanding infrastructure...
FDA Grants RMAT Designation to Avobis Bio’s AVB-114 for Crohn’s Perianal Fistulas
Newark, Del., October 3, 2025 – Avobis Bio LLC, a clinical-stage biotechnology company focused on implantable cell therapies, announced...
Gallant Advances First Ready-to-Use Veterinary Stem Cell Therapy
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
Avant and Austrianova Launch JV for Klotho Cell Therapies
September 18, 2025 — Las Vegas, Nevada Avant Technologies and Austrianova have entered into a Joint Venture and Licensing...
Advertisement
